Textbook
1. Anatomy
2. Microbiology
3. Physiology
4. Pathology
4.1 General pathology
4.2 Central and peripheral nervous system
4.3 Cardiovascular system
4.4 Respiratory system
4.5 Hematology and oncology
4.6 Gastrointestinal pathology
4.6.1 Salivary gland pathology
4.6.2 Esophageal disorders
4.6.3 Diverticula of the esophagus
4.6.4 Stomach
4.6.5 Small intestine
4.6.6 Mesenteric ischemia
4.6.7 Large intestine
4.6.8 Ischemic colitis
4.6.9 Benign and malignant growths of the colon
4.6.10 Rectum and anal canal
4.6.11 Disorders of the liver
4.6.12 Cirrhosis and portal hypertension (PHT)
4.6.13 Benign masses in the liver
4.6.14 Disorders of the gallbladder and bile ducts
4.6.15 Cholangitis
4.6.16 Cholangiocarcinoma
4.6.17 Disorders of the pancreas
4.6.18 Additional information
4.7 Renal, endocrine and reproductive system
4.8 Musculoskeletal system
5. Pharmacology
6. Immunology
7. Biochemistry
8. Cell and molecular biology
9. Biostatistics and epidemiology
10. Genetics
11. Behavioral science
Achievable logoAchievable logo
4.6.2 Esophageal disorders
Achievable USMLE/1
4. Pathology
4.6. Gastrointestinal pathology

Esophageal disorders

  1. Eosinophilic esophagitis: It is a disorder caused by eosinophilic infiltration of the esophagus. It is more common in children and young adults. Many patients have an underlying allergic predisposition to foods or environmental allergens, asthma or eczema. It may be associated with eosinophilic gastroenteritis. Overexpression of the gene eotaxin-3 (chemotactic for eosinophils), mutations in CAPN14 and TSLP have been associated with eosinophilic esophagitis. Enhanced eosinophil chemokine receptor 3 and Th2 mediated immunity is seen. It presents with dysphagia, food impaction, odynophagia (painful swallowing), nausea, weight loss and vomiting. Symptoms may mimic GERD. Diagnosis is by esophagoscopy and biopsy. Endoscopic findings include circular rings (trachealization), linear furrows, whitish plaques, papules and strictures. Biopsy cut-off is >15 eosinophils/high power field infiltrating the esophageal mucosa and submucosa, microabscesses and fibrotic changes . Laboratory findings include eosinophilia. Diet modification by avoiding allergic food ingredients, proton pump inhibitors, steroids and esophageal dilation are used as therapy. Eosinophil blocking antibodies are being investigated as drug therapy.
  2. GERD or gastro-esophageal reflux disease: It is a common disorder characterized by the reflux of gastric contents into the esophagus caused by decreased tone in the lower esophageal sphincter. Increased risk in obesity, alcohol use, tobacco smoking, excess caffeine, pregnancy, sliding hiatal hernia, systemic sclerosis and older age. It presents with heartburn, sour taste, retrosternal chest pain, sensation of a lump in the throat, cough, wheezing, nausea, vomiting etc. Symptoms are exacerbated by big, fatty meals and supine position. Alarm symptoms include dysphagia, odynophagia, weight loss or bleeding. Untreated or long-standing GERD may lead to esophagitis, stricture, metaplastic changes and cancer. Diagnosis is mainly clinical. Ambulatory pH monitoring is considered the gold standard for diagnosing GERD. Acid reflux on pH monitoring manifests as abrupt drops in pH to a level below pH of 4. It allows dynamic monitoring of esophageal pH changes . Upper gastrointestinal or esophageal endoscopy helps to diagnose complications like esophagitis, stricture and Barrett’s esophagus and also enables biopsy. Endoscopy shows erythema and linear ulcers at the distal esophagus. Histologic findings include inflammatory cells like eosinophils, neutrophils and lymphocytes in the epithelium, along with basal cell hyperplasia, ballooning of squamous cells and multinucleated giant cells. Treatment is with lifestyle modification, maintaining healthy weight, H2 blockers and PPIs (more effective). Refractory cases are treated surgically with Nissen fundoplication which reinforces the lower esophageal sphincter.
  3. Barrett’s esophagus (BE): It is a condition in which the normal squamous cell epithelium of the esophagus is replaced by columnar epithelium with goblet cells called intestinal metaplasia, as a response to prolonged acid exposure. Approximately 10-15% of patients with GERD develop Barrett’s esophagus. It may progress to adenocarcinoma of the lower esophagus. Risk factors include male sex, Caucasian race, tobacco smoking and obesity. Screening for BE is done by endoscopy and is recommended in men with chronic GERD with at least 2 risk factors. Criteria to diagnose Barrett’s esophagus are extension of salmon-colored mucosa ≥1 cm proximal to the gastroesophageal junction on endoscopy, and presence of intestinal metaplasia on biopsy evaluation. Management is with PPIs and screening for dysplasia or adenocarcinoma. Endoscopic mucosal resection or endoscopic ablation are done in the presence of dysplasia.
  4. Esophageal carcinomas: It can be of two types-squamous cell or adenocarcinoma. Worldwide, squamous cell carcinomas (SCC) are more common while in the USA, adenocarcinoma is commoner. Risk factors include smoking, alcohol use, city dwellers, eating hot food, high-risk HPV especially HPV-16, Plummer-Vinson syndrome, achalasia, stricture, webs and diverticula. It is more common in African Americans. Adenocarcinoma is seen in the lower esophagus and may develop in a Barrett’s esophagus. Squamous cell carcinomas, on the other hand, are seen in the upper and middle esophagus. Multiple, sequential gene mutations in p53, cyclin D1, HER2, cMYC, EGFR, RB, p16 etc have been found in esophageal cancers. Presentation is often late causing a bad prognosis. Symptoms include progressive dysphagia i.e., difficulty swallowing solids followed over time by dysphagia to liquids, odynophagia or pain while swallowing and weight loss. Squamous cell carcinoma may cause esophageal perforation, fistula formation, mediastinitis or aortic erosion. Metastases occur early to regional lymph nodes, followed by distant metastases to liver, lungs and pleura. Cancers of upper esophagus metastasize to cervical lymph nodes; of mid esophagus to mediastinal, paratracheal and tracheobronchial lymph nodes; of lower esophagus to gastric and celiac lymph nodes. On endoscopy, adenocarcinoma looks like flat patches or nodular masses while SCC looks like plaques, circumferential lesions or ulcerative, cauliflower-like masses. On histology, adenocarcinomas produce mucin and may have signet-ring appearance, with dysplastic changes and intestinal mucosal appearance. SCC shows prickle cells (keratin producing, spinous cells) and concentric keratin pearls.
  5. Achalasia cardia (cardiospasm or megaesophagus): It is a motility disorder of the esophagus characterized by insufficient peristalsis and incomplete relaxation of the lower esophageal sphincter that interferes with passage of food bolus into the stomach. It may be associated with GERD, Barett’s esophagus, aspiration, strictures and carries a risk of progression to SCC of the esophagus. Achalasia results from lack of ganglion cells in the myenteric or Auerbach’s plexus in the lower esophagus. Acquired cases result from Chagas disease, DM, esophageal cancers amyloidosis and sarcoidosis. Clinical features include progressive dysphagia, chest pain, retention of food in esophagus causes regurgitation of food contents, aspiration, cough, weight loss and aspiration pneumonia. CxR and Barium swallow show a massively dilated esophagus with a tapered or “bird’s beak” appearance. Biopsy findings are lymphocytic infiltration in the epithelium, atrophy of submucosal atrophy, absence of ganglion cells, loss of nerve fibres, collagen deposition and muscular hypertrophy. Esophageal manometry shows incomplete relaxation of the LES in response to swallowing, high resting LES pressure and absent esophageal peristalsis. Treatment includes isosorbide mononitrate, nifedipine, botulinum toxin to relax the sphincter, esophagomyotomy (Heller myotomy or peroral endoscopic myotomy) and esophageal dilation.
Achalasia cardia
Achalasia cardia

Manometric schematic of achalasia demonstrating aperistaltic contractions, increased intraesophageal pressure and failure of relaxation of the lower esophageal sphincter.

  1. Diffuse esophageal spasm or corkscrew esophagus: It is a motility disorder of the esophagus characterized by normal or high amplitude, uncoordinated esophageal peristalsis, with normal relaxation of the LES (unlike achalasia). It is caused by degeneration of the vagus nerve with lack of inhibitory parasympathetic innervation. It presents with chest pain and dysphagia to solids and liquids. Hiatal hernia is often associated. Manometry shows intermittently abnormal primary peristalsis associated with a pattern of repetitive, simultaneous, ineffective contractions of varying amplitudes. Barium swallow shows repetitive, lumen-obstructing, non-peristaltic contractions with a typical “corkscrew” or “rosary bead” appearance. Treatment is with calcium channel blockers , hydralazine, nitroglycerine, antidepressants and botulinum toxin.
Diffuse esophageal spasm
Diffuse esophageal spasm
  1. Nutcracker or hyper contracting esophagus: It is an esophageal motility disorder characterized by high amplitude peristaltic contractions in the distal esophagus. It is more common in older females and presents with chest pain, dysphagia and heartburn. Dysphagia is seen to both solids and liquids. It may be confused with IHD or GERD. It often co-exists with psychiatric disturbances, IBS and fibromyalgia. Barium swallow is typically normal or may show abnormal motility. Manometry shows >180 mmHg intraesophageal pressures during peristalsis, repetitive contractions and elevated pressure in the LES, but normally relaxing LES. Medical treatment is done with nitroglycerine, diltiazem, sildenafil and/or antidepressants.

Sign up for free to take 4 quiz questions on this topic